jgordon@claritascapital.com

John is a Senior Associate on the equity investment team.  He contributes to our portfolio of investments and stakeholders with deal sourcing, transaction analysis, industry research, diligence efforts, financial modeling and general board support.  John currently serves on the boards of directors for Apcela and StudioNow, and is a board observer for Alchemy 43, Marinalife, One of None (1/X), and Oversite. John Gordon helps lead Claritas’ support of Esperta Health and Genomind.

Prior to Claritas Capital, John was an Investment Analyst with the long/short Tiger-family hedge fund Tiger Eye Capital. Working directly under the Managing Partner, he headed research for the healthcare and consumer sectors, while also leading growth equity investments in pre-IPO fintech companies and other private equity investments. Before this, John proudly served in the US Army as an Aviation Officer with the 160th Special Operations Aviation Regiment (SOAR). In the military, he piloted heavily modified Special Operations Blackhawk helicopters and led organizations ranging from 25 to 240 soldiers, deploying a cumulative total of 15 months to Afghanistan, Iraq, and other nearby combat locations.

John graduated from the United States Military Academy at West Point in 2010 with a B.S. in Mechanical Engineering, and later graduated from The Wharton School at the University of Pennsylvania in 2021 with an M.B.A. in Finance and Accounting. He is an avid skier, surfer, and mountain biker, lover of the outdoors, and he and his wife are season ticket holders to the Nashville Predators NHL team.